Financial Report 2007

This Information is Intended for Investors

Page 1 of 84
Go to first page Go back one page Go forward one page Go to last page Zoom Plus Zoom Minus Page List Thumb List Email Financial Report Download Full PDF Print Page
Cover Financial Review    Overview of Our Performance and Operating Environment    Overview of Our Performance and Operating Environment    Overview of Our Performance and Operating Environment    Overview of Our Performance and Operating Environment    Overview of Our Performance and Operating Environment    Overview of Our Performance and Operating Environment    Overview of Our Performance and Operating Environment    Overview of Our Performance and Operating Environment    Overview of Our Performance and Operating Environment    Overview of Our Performance and Operating Environment    Accounting Policies    Accounting Policies    Accounting Policies    Analysis of the Consolidated Statement of Income    Revenues    Revenues    Revenues    Revenues - Major Pharmaceutical Products    Revenues - Major Pharmaceutical Products    Revenues - Major Pharmaceutical Products    Revenues - Major Pharmaceutical Products    Revenues - Major Pharmaceutical Products    Animal Health    Costs and Expenses    Costs and Expenses    Costs and Expenses    Adjusted Income    Adjusted Income    Adjusted Income    Adjusted Income    Financial Condition, Liquidity and Capital Resources    Financial Condition, Liquidity and Capital Resources    Financial Condition, Liquidity and Capital Resources    New Accounting Standards    New Accounting Standards    New Accounting Standards    New Accounting Standards    Management's Report on Internal Control Audit Committee's Report Over Financial Reporting    Report of Independent Registered Public Accounting Firm on the Consolidated Financial Statements    Internal Control Over Financial Reporting Consolidated Statements of Income Consolidated Balance Sheets Consolidated Statements of Shareholders' Equity Consolidated Statements of Cash Flows Notes to Consolidated Financial Statements    Note 1 - Significant Accounting Policies    Note 1 - Significant Accounting Policies    Note 1 - Significant Accounting Policies    Note 2 - Acquisitions    Note 3 - Discontinued Operations    Note 4 - Asset Impairment Charges and Other Costs Associated with Exiting Exubera    Note 5 - Cost-Reduction Initiatives    Note 6 - Acquisition-Related Costs    Note 7 - Other (Income)/Deductions-Net    Note 8 - Taxes on Income    Note 8 - Taxes on Income    Note 8 - Taxes on Income    Note 8 - Taxes on Income    Note 9 - Other Comprehensive Income/(Expense)    Note 10 - Financial Instruments    Note 10 - Financial Instruments    Note 10 - Financial Instruments    Note 11 - Inventories    Note 12 - Property, Plant and Equipment    Note 13 - Goodwill and Other Intangible Assets    Note 14 - Pension and Postretirement Benefit Plans and Defined Contribution Plans    Note 14 - Pension and Postretirement Benefit Plans and Defined Contribution Plans    Note 14 - Pension and Postretirement Benefit Plans and Defined Contribution Plans    Note 14 - Pension and Postretirement Benefit Plans and Defined Contribution Plans    Note 14 - Pension and Postretirement Benefit Plans and Defined Contribution Plans    Note 14 - Pension and Postretirement Benefit Plans and Defined Contribution Plans    Note 15 - Equity    Note 16 - Share-Based Payments    Note 16 - Share-Based Payments    Note 16 - Share-Based Payments    Note 16 - Share-Based Payments    Note 17 - Earnings per Common Share    Note 18 - Earnings per Common Share    Note 19 - Insurance    Note 20 - Legal Proceedings and Contingencies    Note 20 - Legal Proceedings and Contingencies    Note 20 - Legal Proceedings and Contingencies    Note 20 - Legal Proceedings and Contingencies    Note 20 - Legal Proceedings and Contingencies    Note 20 - Legal Proceedings and Contingencies    Note 20 - Legal Proceedings and Contingencies    Note 20 - Legal Proceedings and Contingencies    Note 21 - Segment, Geographic and Revenue Information    Note 21 - Segment, Geographic and Revenue Information    Note 21 - Segment, Geographic and Revenue Information Quarterly Consolidated Financial Data (Unaudited) 2007 Quarterly Consolidated Financial Data (Unaudited) 2006 Financial Summary Peer Group Performance Graph
Cover Financial Review    Overview of Our Performance and Operating Environment    Accounting Policies    Analysis of the Consolidated Statement of Income    Revenues    Revenues - Major Pharmaceutical Products    Animal Health    Costs and Expenses    Adjusted Income    Financial Condition, Liquidity and Capital Resources    New Accounting Standards    Management's Report on Internal Control Audit Committee's Report Over Financial Reporting    Report of Independent Registered Public Accounting Firm on the Consolidated Financial Statements    Internal Control Over Financial Reporting Consolidated Statements of Income Consolidated Balance Sheets Consolidated Statements of Shareholders' Equity Consolidated Statements of Cash Flows Notes to Consolidated Financial Statements    Note 1 - Significant Accounting Policies    Note 2 - Acquisitions    Note 3 - Discontinued Operations    Note 4 - Asset Impairment Charges and Other Costs Associated with Exiting Exubera    Note 5 - Cost-Reduction Initiatives    Note 6 - Acquisition-Related Costs    Note 7 - Other (Income)/Deductions-Net    Note 8 - Taxes on Income    Note 9 - Other Comprehensive Income/(Expense)    Note 10 - Financial Instruments    Note 11 - Inventories    Note 12 - Property, Plant and Equipment    Note 13 - Goodwill and Other Intangible Assets    Note 14 - Pension and Postretirement Benefit Plans and Defined Contribution Plans    Note 15 - Equity    Note 16 - Share-Based Payments    Note 17 - Earnings per Common Share    Note 18 - Earnings per Common Share    Note 19 - Insurance    Note 20 - Legal Proceedings and Contingencies    Note 21 - Segment, Geographic and Revenue Information Quarterly Consolidated Financial Data (Unaudited) 2007 Quarterly Consolidated Financial Data (Unaudited) 2006 Financial Summary Peer Group Performance Graph
Advisory Information for Investors
Page 1 of 84
Go to first page Go back one page Go forward one page Go to last page Zoom Plus Zoom Minus Page List Thumb List Email Financial Report Download Full PDF Print Page